Digital Intervention to Protect Cognitive Health; Afib Ablation and Quality of Life
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of Texas Tech Health El Paso, look at the top medical...
Rick Lange, president of Texas Tech Health El Paso, discussed a study on catheter-directed thrombolysis for intermediate and high-risk pulmonary embolism. The study, conducted in the Czech Republic, randomized 558 patients, 280 to a thrombolysis group and 278 to a standard-care group using medicines to dissolve clots. The primary outcome measured the composite of death, recurrence of PE, cardiorespiratory decompensation, or collapse within 7 days after randomization.
The study found that the thrombolysis group had a lower incidence of cardiorespiratory decompensation or collapse compared to the standard-care group. However, clinically relevant bleeding occurred at a similar rate in both groups. One patient in the thrombolysis group died within 30 days, while four patients in the standard care group died.
Written by urgent.news from MedPage Today's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
